Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Cooksley

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
Acta Anaesthesiologica Scandinavica|November 7, 2018
Impaired mobility is associated with risk of ICU admission but not outcome after ICU treatmentSøren K Nissen, Mikkel Brabrand, Christian H Nickel, et al.
European Journal of Internal Medicine|March 5, 2025
Utilizing D-dimer levels for predicting survival probability in unplanned hospital admissions: Insights from a 5-year nationwide population-based register studyMikkel Brabrand, Marianne Fløjstrup, Søren Bie Bogh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 25, 2023
The need for ambulatory emergency oncology: exemplified by the management of immune checkpoint inhibitor toxicityTim Cooksley, Adam Klotz, Ernie Marshall, et al.
Breast (Edinburgh, Scotland)|July 27, 2025
Acute presentations in neoadjuvant chemotherapy/immune checkpoint inhibition for triple negative breast cancer: experiences and impact from real-world dataTim Cooksley, Safwaan Adam, Bence Nagy, et al.
Expert Review of Clinical Pharmacology|February 1, 2021
Treatment of infections in cancer patients: an update from the neutropenia, infection and myelosuppression study group of the Multinational Association for Supportive Care in Cancer (MASCC)Bernardo L Rapoport, Tim Cooksley, Douglas B Johnson, et al.
Acute Medicine|January 5, 2016
Society for Acute Medicine Benchmarking Audit 2015: The Patient PerspectiveSara Pradhan, Deysha Ratnasingham, Christian P Subbe, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 17, 2025
Low-risk febrile neutropenia: does combined chemotherapy/immune checkpoint inhibitor necessitate a change in approach?Jamie M J Weaver, Bence Nagy, Caroline Wilson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 24, 2020
Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paperTim Cooksley, Carme Font, Florian Scotte, et al.
Eclinicalmedicine|February 15, 2020
Advance care planning in patients referred to hospital for acute medical care: Results of a national day of care surveyThomas Knight, Alexandra Malyon, Zoe Fritz, et al.
Internal and Emergency Medicine|January 3, 2021
Routine measurement of d-dimers on suspected SARS-CoV2-infected patients does not lead to significant increase in radiological investigationsMikkel Brabrand, Søren Bie Bogh, Marianne Fløjstrup, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Acta Anaesthesiologica Scandinavica|November 7, 2018
Impaired mobility is associated with risk of ICU admission but not outcome after ICU treatmentSøren K Nissen, Mikkel Brabrand, Christian H Nickel, et al.
European Journal of Internal Medicine|March 5, 2025
Utilizing D-dimer levels for predicting survival probability in unplanned hospital admissions: Insights from a 5-year nationwide population-based register studyMikkel Brabrand, Marianne Fløjstrup, Søren Bie Bogh, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 25, 2023
The need for ambulatory emergency oncology: exemplified by the management of immune checkpoint inhibitor toxicityTim Cooksley, Adam Klotz, Ernie Marshall, et al.
Breast (Edinburgh, Scotland)|July 27, 2025
Acute presentations in neoadjuvant chemotherapy/immune checkpoint inhibition for triple negative breast cancer: experiences and impact from real-world dataTim Cooksley, Safwaan Adam, Bence Nagy, et al.
Expert Review of Clinical Pharmacology|February 1, 2021
Treatment of infections in cancer patients: an update from the neutropenia, infection and myelosuppression study group of the Multinational Association for Supportive Care in Cancer (MASCC)Bernardo L Rapoport, Tim Cooksley, Douglas B Johnson, et al.
Acute Medicine|January 5, 2016
Society for Acute Medicine Benchmarking Audit 2015: The Patient PerspectiveSara Pradhan, Deysha Ratnasingham, Christian P Subbe, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 17, 2025
Low-risk febrile neutropenia: does combined chemotherapy/immune checkpoint inhibitor necessitate a change in approach?Jamie M J Weaver, Bence Nagy, Caroline Wilson, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 24, 2020
Emerging challenges in the evaluation of fever in cancer patients at risk of febrile neutropenia in the era of COVID-19: a MASCC position paperTim Cooksley, Carme Font, Florian Scotte, et al.
Eclinicalmedicine|February 15, 2020
Advance care planning in patients referred to hospital for acute medical care: Results of a national day of care surveyThomas Knight, Alexandra Malyon, Zoe Fritz, et al.
Internal and Emergency Medicine|January 3, 2021
Routine measurement of d-dimers on suspected SARS-CoV2-infected patients does not lead to significant increase in radiological investigationsMikkel Brabrand, Søren Bie Bogh, Marianne Fløjstrup, et al.
Pageof 11